MapLight Therapeutics MPLT
NASDAQ MPLT
$7.48 +0.04 (+0.54%)
At close: Nov 11, 2026 · 4:00 PM EST

MapLight Therapeutics (MPLT) Change in Accrued Expenses (2024 - 2026)

Updated

MapLight Therapeutics (MPLT) posted Change in Accrued Expenses of $1.12 million for Q4 2025, down 6.7% from $1.21 million a year earlier and down 57.0% from the prior quarter.

Analysis

MapLight Therapeutics (MPLT) Change in Accrued Expenses (2024 - 2026) Analysis & Trends

For FY2025, MapLight Therapeutics' Change in Accrued Expenses came in at $2.9 million, up 33.7% from FY2024.

  • In prior years, MapLight Therapeutics' Change in Accrued Expenses was $2.17 million in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Accrued Exp. (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 2.41 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 983.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -87.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 756.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 MapLight Therapeutics 338.05 Mn 33.33 Mn - 5.84 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 5.84 Mn
Mar 31, 2026 -1.88 Mn
Dec 31, 2025 1.12 Mn
Sep 30, 2025 2.61 Mn
Jun 30, 2025 1.28 Mn
Mar 31, 2025 -2.12 Mn
Dec 31, 2024 1.21 Mn
API Access

MapLight Therapeutics Change in Accrued Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=MPLT&period=max&api_key=YOUR_API_KEY